TRIM21 and systemic sclerosis: Indeed, cancer-associated scleroderma was more frequently reported when anti-Ro52 was found to be the sole autoantibody, whereas its positivity in combination with other specificities correlated with higher rates of overall cancer throughout the disease history of patients with SSc (137).